ADGM
Adagio Medical Holdings, Inc Common StockNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$27.76M
P/E Ratio
—
EPS
$-1.51
Beta
0.04
52W High
$2.58
52W Low
$0.73
50-Day MA
$1.05
200-Day MA
$1.25
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc. is a pioneering biotech firm specializing in advanced medical technologies tailored for the treatment of cardiac arrhythmias. Through its proprietary platform, the company is innovating targeted ablation techniques that address critical needs within the electrophysiology market. With a robust product pipeline and a seasoned leadership team, Adagio presents an attractive opportunity for institutional investors aiming to engage in the evolving landscape of healthcare innovation and improve patient outcomes in the cardiac sector.
Fundamentals
| Revenue (TTM) | 137,000 |
| Gross Profit (TTM) | -684,000 |
| EBITDA | $-20.92M |
| Operating Margin | 0.00% |
| Return on Equity | -155.20% |
| Return on Assets | -29.80% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.56 |
| Price-to-Book | 2.19 |
| Price-to-Sales (TTM) | 205.85 |
| EV/Revenue | 370.25 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 75.60% |
| Shares Outstanding | $22.21M |
| Float | $4.81M |
| % Insiders | 2.40% |
| % Institutions | 75.39% |
Analyst Ratings
Consensus ($4.00 target)
1
BuyData last updated: 4/7/2026